2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 291.052 | 226.996 | 186.126 | 183.542 | 176.083 | 176.910 | 200.944 | 167.903 | 152.184 | 17 |
Total Income - EUR | 291.862 | 227.586 | 186.318 | 183.742 | 176.393 | 177.056 | 201.095 | 170.039 | 429.024 | 120 |
Total Expenses - EUR | 296.222 | 234.675 | 190.887 | 199.721 | 188.273 | 204.872 | 204.862 | 176.595 | 157.752 | 2.526 |
Gross Profit/Loss - EUR | -4.360 | -7.089 | -4.569 | -15.979 | -11.879 | -27.816 | -3.768 | -6.556 | 271.272 | -2.406 |
Net Profit/Loss - EUR | -4.409 | -7.089 | -4.569 | -17.641 | -13.641 | -29.587 | -5.516 | -8.236 | 267.068 | -2.407 |
Employees | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | 1 |
Check the financial reports for the company - Elmedica Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 2.264 | 1.711 | 40.081 | 29.063 | 19.634 | 13.632 | 6.155 | 6.050 | 18.475 | 18.419 |
Current Assets | 97.227 | 80.216 | 76.016 | 53.726 | 47.805 | 48.139 | 42.329 | 35.659 | 194.041 | 18.140 |
Inventories | 92.766 | 69.265 | 58.572 | 49.491 | 41.358 | 41.480 | 35.463 | 30.647 | 0 | 0 |
Receivables | 2.930 | 7.276 | 7.616 | 1.837 | 1.850 | 5.506 | 5.444 | 4.755 | 7.243 | 4 |
Cash | 1.531 | 3.675 | 9.828 | 2.398 | 4.597 | 1.153 | 1.423 | 258 | 186.797 | 18.135 |
Shareholders Funds | 61.265 | 54.687 | -4.209 | -21.779 | -35.020 | -63.928 | -70.853 | -77.518 | 189.309 | 21.521 |
Social Capital | 45 | 45 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 |
Debts | 38.502 | 27.530 | 120.716 | 104.981 | 102.865 | 126.097 | 119.337 | 119.227 | 23.206 | 15.038 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Elmedica Srl